BioNTech hopes to move into cancer drugs
Losses at German pharmaceutical company BioNTech quadrupled in the second quarter compared to the previous year. Now the company is confident in a change of strategy towards new cancer treatments after a sharp drop in sales of its COVID-19 vaccine. BioNTech reported a second-quarter net loss of €807.8 million.
POPULAR POSTS
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVE STREAM